Effect of supplementation of women in high-risk pregnancies with long-chain polyunsaturated fatty acids on pregnancy outcomes and growth measures at birth
Citation: Horvath A., Koletzko B., & Szajewska H. Effect of supplementation of women in high-risk pregnancies with long-chain polyunsaturated fatty acids on pregnancy outcomes and growth measures at birth: a meta-analysis of randomized controlled trials. British Journal of Nutrition, 2007;98(02):253
The present data suggest that supplementation with n-3 long chain polyunsaturated fatty acids (LC-PUFA) in women with high-risk pregnancies reduced the risk of early preterm delivery in the fatty acid-supplemented group compared with the placebo group, while no other effects on pregnancy outcomes were detected.
LC-PUFTA intake during pregnancy has been considered to have positive effects on pre-eclampsia, pregnancy-induced hypertension or intra-uterine growth retardation, and is essential for optimal neural development. This review aimed to evaluate the effects of LC-PUFTA supplementation to the diets of women with high-risk pregnancies on pregnancy outcomes and growth measures at birth. Four randomized or quazi-randomized trials with 1264 participants were included in this review, independently reviewed according to inclusion criteria by two separate reviewers. Results showed no evidence for the effect of LC-PUFTA on the duration of pregnancy or the percentage of preterm deliveries however, a significantly lower rate of early preterm delivery was observed. No significant difference in infant birth weight, rate of low birth weight and recurrence of intra-uterine growth retardation was observed. Other pregnancy outcomes were noted to be of little difference in the control and supplementation groups.
Disclaimer: This summary has been written by staff and volunteers of Evidence Aid in order to make the content of the original document accessible to decision makers who are searching for the available evidence the prevention and treatment of malnutrition but may not have the time, initially, to read the original report in full. This summary is not intended as a substitute for the medical advice of physicians, other health workers, professional associations, guideline developers, or national governments and international agencies. If readers of this summary think that the evidence that is presented within it is relevant to their decision-making they should refer to the content and details of the original article, and the advice and guidelines offered by other sources of expertise, before making decisions. Evidence Aid cannot be held responsible for any decisions made about prevention or treatment of malnutirition on the basis of this summary alone.
We’ve already reached tens of thousands of people with plain language summaries of systematic reviews. If you’d like to help us to continue our work, please consider a donation.
Donate with PayPal
You can also donate through the Charities Aid Foundation (CAF) here. If you are based in the USA and want to make a tax-deductable donation, please donate to Evidence Aid via the British Schools and Universities Foundation.